The standard of care for treating vestibular dysfunction has been long overdue for a technological breakthrough.
Traditional vestibular therapy relies on manual techniques that require substantial patient effort and therapist skill. Outcomes are limited by a patient’s physical and cognitive capacity—and by a therapist’s ability to deliver consistent, precise care. These limitations reduce therapeutic intensity, compromise safety, prolong recovery, and too often result in suboptimal outcomes. For millions of individuals with mobility or cognitive impairments, manual therapy isn’t just difficult—it’s often impossible.
While nearly every branch of medicine has advanced through technology, vestibular rehabilitation therapy has remained stagnant—until now.
GyroStim's technological advantage changes everything.
GyroStim replaces the inconsistencies of manual therapy with fully automated, computer-controlled precision. Its data-driven, multi-axis motion platform delivers high-intensity vestibular, visual, and cognitive stimulation—simultaneously and with unmatched precision, repeatability, and safety.
The result?
A safer, more accessible, and vastly more effective treatment experience—unlike anything else available today.
GyroStim is the first and only vestibular therapy device to earn the FDA’s prestigious Breakthrough Device designation—a recognition of its technological superiority and its potential to deliver significantly better outcomes than the outdated standard of care.